Hospitalized patients with advanced COVID-19 who received remdesivir recovered faster than those who received placebo: NIAID
Apr 30, 2020
Washington D.C. [US], April 30 : A preliminary data analysis from NIH clinical trial shows that hospitalized patients with "advanced COVID-19 and lung involvement who received the investigational antiviral remdesivir recovered faster than similar patients who received placebo".